NCT00669162 Postoperative Radiation Therapy, Hormonal Therapy and Concurrent Docetaxel for High Risk Pathologic Prostate Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00668642 Effect of Dutasteride on Androgen-Response Gene Expression in Patients With Advanced Prostate Cancer Status COMPLETED Phase PHASE2
NCT00668083 Observational Retrospective Trial on Sequential Hormonal Therapy in Patients With Prostate Cancer Status COMPLETED Phase N/A
NCT00667888 A Phase III Intensity Radiotherapy Dose Escalation for Prostate Cancer Using Hypofractionation Status UNKNOWN Phase PHASE3
NCT00667862 Efficacy and Safety Study of Panobinostat in Participants With Metastatic Hormone Refractory Prostate Cancer Status COMPLETED Phase PHASE2
NCT00667641 Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors Status COMPLETED Phase PHASE1
NCT00667069 Triptorelin and Radiation Therapy in Treating Patients Who Have Undergone Surgery for Intermediate-Risk Stage III or Stage IV Prostate Cancer Status COMPLETED Phase PHASE3
NCT00664456 Luteinizing Hormone-Releasing Hormone Agonist Therapy and Iodine I 125 Implant in Treating Patients With Previously Untreated Prostate Cancer Status COMPLETED Phase PHASE3
NCT00664196 Trial of Anti-PSMA Designer T Cells in Advanced Prostate Cancer After Non-Myeloablative Conditioning Status SUSPENDED Phase PHASE1
NCT00663832 A Dose Finding Study With I.V. Panobinostat (LBH589), Docetaxel, and Prednisone in Patients With Hormone Refractory Prostate Cancer Status COMPLETED Phase PHASE1
NCT00659438 Efficacy and Safety of Zactima™ in Patients With Castration-refractory Metastatic Prostate Cancer Status COMPLETED Phase PHASE2
NCT00658697 Docetaxel, Bevacizumab and Androgen Deprivation Therapy After Definitive Local Therapy for Prostate Cancer Status COMPLETED Phase PHASE2
NCT00657982 Phase II Study of RAD001 in a Neoadjuvant Setting in Men With Intermediate or High Risk Prostate Cancer Status UNKNOWN Phase PHASE2
NCT00654186 Study Evaluating Toxicity & Efficacy of Lenalidomide(Revlimid®)in Chemotherapy-Naïve AIPC Patients Status COMPLETED Phase PHASE2
NCT00653848 Adjuvant Treatment of Prostate Cancer With Docetaxel or Not After Radical Radiotherapy Status UNKNOWN Phase PHASE3
NCT00653757 Intensity-Modulated Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IV Prostate Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00651326 Androgen Suppression and Radiation With/Out Docetaxel in High-Risk Localized Prostate Cancer Status TERMINATED Phase PHASE3